Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide BE and Efficacy in Chronic Idiopathic Constipation
CTR20210484Phase 3Terminated
- Sponsor
- Hengrui Therapeutics
- Start
- Mar 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of linaclotide in functional constipation (FC), sponsored by Hengrui Therapeutics. Started Mar 2021; status: terminated.
02
Drugs
linaclotide
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on CTR20210484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210484.